US equities |
SPCX $167.11 ▲+5.13% NVDA $237.10 ▲+1.35% MU $1,064.47 ▼-0.97% TSLA $377.88 ▲+1.97% MSFT $527.16 ▲+1.86% SNDK $1,715.13 ▼-0.28% INTC $116.62 ▼-2.27% META $746.05 ▲+2.47%
FinancialContent

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.340 +0.010 (+0.75%)
Delayed Quote Updated: 11:05 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InMed Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Marijuana Stock Movers For August 15, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Gainers And Losers From July 25, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Gainers And Losers From August 11, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Movers For July 21, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Movers For August 10, 2023 ↗
 
Via Benzinga
Topics Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series
Via CannabisNewsWire
Topics Supply Chain
News headline image
Marijuana Stock Movers For August 8, 2023 ↗
 
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series
Via Investor Brand Network
Topics Supply Chain
News headline image
Marijuana Stock Movers For August 1, 2023 ↗
 
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business
Via CannabisNewsWire
Topics Supply Chain
News headline image
Cannabis Stock Movers For July 24, 2023 ↗
 
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business
Via Investor Brand Network
Topics Supply Chain
News headline image
Cannabis Stock Movers For July 20, 2023 ↗
 
Via Benzinga
News headline image
Game-Changer In Epidermolysis Bullosa Treatment? Cannabis Compound Holds Promise ↗
In a positive step for the treatment of the rare genetic dermatological condition known as epidermolysis bullosa (EB), InMed Pharmaceuticals Inc. (NASDAQ: INM) has published top-line data from its... 
Via Benzinga
News headline image
Why Are InMed Pharmaceuticals Stock Trading Lower Today ↗
InMed Pharmaceuticals Inc (NASDAQ: INM) shares are trading lower after the company released safety and efficacy results from its Phase 2 clinical trial (755-201-EB) for  
Via Benzinga
News headline image
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) 755-201-EB Trial Demonstrates Clinically Important Results
Via Investor Brand Network
News headline image
Study Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's Treatment ↗
The study focused on the potential of rare cannabinoids in the treatment of neurodegenerative diseases like Alzheimer's. According to the researchers behind the study, this breakthrough research opens... 
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Sponsored Research Presented at Canadian Neuroscience Meeting
Via CannabisNewsWire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Sponsored Research Presented at Canadian Neuroscience Meeting
Via Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Participate in Virtual Investor Events Next Week
Via Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Participate in Virtual Investor Events Next Week
Via CannabisNewsWire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO Featured in Upcoming Water Tower Research Fireside Chat
Via CannabisNewsWire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO Featured in Upcoming Water Tower Research Fireside Chat
Via Investor Brand Network
News headline image
InMed Pharmaceuticals Stock Trading Higher On Q3 Sales Growth Of 234%, Here Is What You Need To Know ↗
InMed Pharmaceuticals Inc. (NASDAQ: INM) released its financial results for the third quarter of the fiscal year 2023 which ended March 31, 2023, revealing sales of $1 million, an increase of 234%... 
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update
Via Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update
Via CannabisNewsWire
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Concludes Enrollment for Phase 2 Trial Studying INM-755 Cannabinol Cream
Via Investor Brand Network
News headline image
InMed Pharmaceuticals: Pushing Pharma Forward With Rare Cannabinoids ↗
Jerry Griffin, VP of Sales & Marketing at BayMedica, Inc. – a subsidiary of InMed Pharmaceuticals Inc (NASDAQ: INM) – was a guest on Benzinga’s All Access. 
Via Benzinga
News headline image
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >